Latest SPAC Liquidations: Pivotal Investment Corp. III
Pivotal Investment Corporation III (PICC) to Liquidate
As previously disclosed, Pivotal Investment Corporation III (OTC:PICC) had called a special meeting of stockholders to consider and vote on an extension. The meeting was originally scheduled for August 2, but the company adjourned the meeting to August 11 to allow additional time to engage with stockholders and effectuate redemption reversals.
Based on the number of public shares that stockholders were seeking to redeem for cash and other factors that it deemed relevant, the company’s management determined that the extension was no longer in the best interests of the company and its stockholders.
Accordingly, on August 11, the company reconvened the meeting and then closed it without considering any business.
As a result, the company expects to redeem 100% of its outstanding public shares.
READ
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...